Log in

OTCMKTS:ACURAcura Pharmaceuticals Stock Price, Forecast & News

$0.32
-0.02 (-5.97 %)
(As of 06/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.31
Now: $0.32
$0.35
50-Day Range
$0.14
MA: $0.31
$0.40
52-Week Range
$0.12
Now: $0.32
$0.63
Volume6,206 shs
Average Volume14,019 shs
Market Capitalization$6.82 million
P/E RatioN/A
Dividend YieldN/A
Beta1.12
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of technologies and products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.
Read More
Acura Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolOTCMKTS:ACUR
Previous SymbolNASDAQ:ACUR
CUSIP00509L70
Phone847-705-7709

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.66 million
Book Value($0.22) per share

Profitability

Net Margins-142.04%

Miscellaneous

Employees14
Market Cap$6.82 million
Next Earnings Date10/6/2020 (Estimated)
OptionableNot Optionable

Receive ACUR News and Ratings via Email

Sign-up to receive the latest news and ratings for ACUR and its competitors with MarketBeat's FREE daily newsletter.

Acura Pharmaceuticals (OTCMKTS:ACUR) Frequently Asked Questions

How has Acura Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Acura Pharmaceuticals' stock was trading at $0.34 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACUR stock has decreased by 7.4% and is now trading at $0.3150. View which stocks have been most impacted by Coronavirus.

When is Acura Pharmaceuticals' next earnings date?

Acura Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, October 6th 2020. View our earnings forecast for Acura Pharmaceuticals.

How were Acura Pharmaceuticals' earnings last quarter?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) announced its quarterly earnings results on Friday, February, 28th. The specialty pharmaceutical company reported $0.00 EPS for the quarter. The specialty pharmaceutical company had revenue of $1.32 million for the quarter. View Acura Pharmaceuticals' earnings history.

Has Acura Pharmaceuticals been receiving favorable news coverage?

Press coverage about ACUR stock has trended extremely negative this week, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Acura Pharmaceuticals earned a media sentiment score of -4.6 on InfoTrie's scale. They also gave news articles about the specialty pharmaceutical company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutAcura Pharmaceuticals.

Who are some of Acura Pharmaceuticals' key competitors?

What other stocks do shareholders of Acura Pharmaceuticals own?

Who are Acura Pharmaceuticals' key executives?

Acura Pharmaceuticals' management team includes the following people:
  • Mr. Robert B. Jones, CEO, Pres & Director (Age 60)
  • Mr. Peter A. Clemens, Sr. VP, CFO & Sec. (Age 66)
  • Mr. James F. Emigh, VP of Corp. Devel. (Age 63)
  • Mr. Robert A. Seiser Ph.D., VP, Treasurer & Corp. Controller (Age 55)

What is Acura Pharmaceuticals' stock symbol?

Acura Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ACUR."

How do I buy shares of Acura Pharmaceuticals?

Shares of ACUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Acura Pharmaceuticals' stock price today?

One share of ACUR stock can currently be purchased for approximately $0.32.

How big of a company is Acura Pharmaceuticals?

Acura Pharmaceuticals has a market capitalization of $6.82 million and generates $2.66 million in revenue each year. Acura Pharmaceuticals employs 14 workers across the globe.

What is Acura Pharmaceuticals' official website?

The official website for Acura Pharmaceuticals is www.acurapharm.com.

How can I contact Acura Pharmaceuticals?

Acura Pharmaceuticals' mailing address is 616 N. NORTH COURT SUITE 120, PALATINE IL, 60067. The specialty pharmaceutical company can be reached via phone at 847-705-7709 or via email at [email protected]

This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.